We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$86.5M
AUM Growth
-$66.5M
Cap. Flow
-$70.6M
Cap. Flow %
-81.66%
Top 10 Hldgs %
8.13%
Holding
435
New
164
Increased
25
Reduced
63
Closed
183

Top Buys

Rank Stock Value
1
MLKN icon
MillerKnoll
MLKN
+$754K
2
LEN icon
Lennar Class A
LEN
+$740K
3
HXL icon
Hexcel
HXL
+$733K
4
CNK icon
Cinemark Holdings
CNK
+$732K
5
FAF icon
First American
FAF
+$732K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.61%
2 Industrials 15.51%
3 Financials 14.29%
4 Technology 14.02%
5 Healthcare 12.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETFC
176
DELISTED
E*Trade Financial Corporation
ETFC
$147K 0.17%
+3,241
New +$138K
DOC
177
DELISTED
PHYSICIANS REALTY TRUST
DOC
$141K 0.16%
7,453
+7,228
+3,212% +$133K
IRWD icon
178
Ironwood Pharmaceuticals
IRWD
$714M
$134K 0.16%
+10,081
New +$111K
ISBC
179
DELISTED
Investors Bancorp, Inc.
ISBC
$134K 0.16%
+11,235
New +$135K
MCK icon
180
McKesson
MCK
$101B
$131K 0.15%
945
-3,696
-80% -$522K
TAL icon
181
TAL Education Group
TAL
$6.87B
$130K 0.15%
+2,702
New +$116K
NYT icon
182
New York Times
NYT
$10.2B
$124K 0.14%
+3,866
New +$120K
PWR icon
183
Quanta Services
PWR
$101B
$124K 0.14%
3,041
-16,954
-85% -$692K
PFPT
184
DELISTED
Proofpoint, Inc.
PFPT
$119K 0.14%
1,037
-1,572
-60% -$187K
EXEL icon
185
Exelixis
EXEL
$13.4B
$114K 0.13%
6,461
-25,825
-80% -$438K
FOLD
186
DELISTED
Amicus Therapeutics
FOLD
$111K 0.13%
+11,348
New +$104K
PRKS icon
187
United Parks & Resorts
PRKS
$2.12B
$108K 0.12%
3,395
-4,010
-54% -$116K
KIM icon
188
Kimco Realty
KIM
$16.4B
$107K 0.12%
5,145
-25,412
-83% -$533K
FSLR icon
189
First Solar
FSLR
$26.9B
$103K 0.12%
+1,834
New +$101K
LSCC icon
190
Lattice Semiconductor
LSCC
$18.5B
$91K 0.11%
+4,735
New +$90.9K
SGI
191
Somnigroup International
SGI
$13.7B
$89K 0.1%
4,092
-18,208
-82% -$381K
MPC icon
192
Marathon Petroleum
MPC
$83.7B
$87K 0.1%
+1,446
New +$90.5K
TTWO icon
193
Take-Two Interactive
TTWO
$46.1B
$82K 0.09%
+667
New +$81.2K
WRI
194
DELISTED
Weingarten Realty Investors
WRI
$80K 0.09%
2,554
+2,371
+1,296% +$72.5K
PTCT icon
195
PTC Therapeutics
PTCT
$6.12B
$77K 0.09%
+1,613
New +$68.5K
TT icon
196
Trane Technologies
TT
$106B
$74K 0.09%
+559
New +$70.8K
PENN icon
197
PENN Entertainment
PENN
$2.71B
$71K 0.08%
+2,790
New +$62K
CINF icon
198
Cincinnati Financial
CINF
$27.1B
$69K 0.08%
+657
New +$71.8K
ABMD
199
DELISTED
Abiomed Inc
ABMD
$69K 0.08%
+405
New +$75.1K
GDDY icon
200
GoDaddy
GDDY
$11.5B
$55K 0.06%
810
-14,662
-95% -$969K

Similar funds

Neo Ivy Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Neo Ivy Capital Management held 435 positions worth $86.5M, down 43% from $153M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Neo Ivy Capital Management withdrew a net $70.6M in Q4 2019, closing 183 positions and reducing 63 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.29M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

Against the trend, Neo Ivy Capital Management opened a new position in MillerKnoll worth $678K.

  • Neo Ivy Capital Management's largest Q4 2019 buy was MillerKnoll: 16,277 shares worth $678K.
  • Neo Ivy Capital Management added most to CVS Health in Q4 2019, an estimated $657K increase.
  • Neo Ivy Capital Management's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $1.34M.
  • Neo Ivy Capital Management fully exited Alexion Pharmaceuticals in Q4 2019, selling an estimated $1.29M.
  • Neo Ivy Capital Management's ten largest holdings make up 8.1% of its $86.5M portfolio in Q4 2019.
  • Neo Ivy Capital Management opened 164 new positions and closed 183 in Q4 2019.
  • Neo Ivy Capital Management's portfolio value fell 43% quarter-over-quarter to $86.5M.

Based on Neo Ivy Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.